Page 2 - Markw Hahn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Verona Pharma plc (NASDAQ:VRNA – Get Rating) has received a consensus rating of “Buy” from the six brokerages that are covering the company, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a buy recommendation. The average 12 month target price among brokerages that have issued ratings on the stock in the […]

06.01.2022 - ALSP Orchid Acquisition Corporation I (Nasdaq: ALORU) (the “Company” or “ALSP Orchid”) announced today that, commencing January 10, 2022, holders of the units sold in the Company’s initial public offering of 172,500,000 units, completed on November ...